Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -2.334% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a CCN1CCCC1CNC(=O)Cn1ncc2c(=O)oc3ccc(C)cc3c21
b Cc1ccc(C(c2nnnn2CCc2ccccc2)N2CCC(C)CC2)cc1.Cl
c O=C(CC1C(=O)NCCN1Cc1cccc(F)c1)NCCCCCN1CCOCC1
d CC(C)c1ccc(Nc2nnc(SCC(=O)Nc3ncc(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)s3)s2)cc1
e Cc1cc(NC(=O)CSc2nc3ccccc3c(=O)n2CCCC(=O)NCc2ccco2)n[nH]1
Answer: a. CCN1CCCC1CNC(=O)Cn1ncc2c(=O)oc3ccc(C)cc3c21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCCC1CNC(=O)Cn1ncc2c(=O)oc3ccc(C)cc3c21
CCN1CCCC1CNC(=O)Cn1ncc2c(=O)oc3ccc(C)cc3c21
N-[(1-ethylpyrrolidin-2-yl)methyl]-2-(8-methyl-4-oxochromeno[4,3-c]pyrazol-1-yl)acetamide